Largest Ever CIDP Clinical Study Completed PATH study evaluated subcutaneous immunoglobulin efficacy and safety for treating Chronic Inflammatory Demyelinating Polyneuropathy KING OF PRUSSIA, Pa. – 01 March 2017 – Global biotherapeutics leader CSL Behring announced today that it has completed the largest ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, known as PATH (Polyneuropathy And Treatment […]
GBS|CIDP Foundation International Named to the 2016 Classy 100 Recognized as a consistent growing nonprofit on the leading online fundraising platform in 2016 Narberth, Pennsylvania – GBS|CIDP Foundation International made this year’s Classy 100 list, an annual compilation of the growing nonprofits on Classy, the world’s leading online fundraising platform for social enterprises. Classy […]
PPTA Interview: Lisa Butler, Executive Director of the GBS|CIDP Foundation International BY JULIE BIRKOFER, PPTA SENIOR VICE PRESIDENT, NORTH AMERICA & GLOBAL HEALTH POLICY Can you tell me about the GBS|CIDP Foundation and the work you do? We were founded 35 years ago by Estelle Benson. Her husband, Bob Benson, was diagnosed with GBS and […]
Interlaken Leadership Awards The Interlaken Leadership Awards support original research in the field of neuroimmunology. Investigators whose proposals are approved by the review committee will receive monetary grants and/or drug supply. The size of the individual grants is not predetermined, in order to accommodate a wide variety of investigator needs. However small innovative trials […]
Brand new to our Foundation! A little spirit of a chapter meeting & a taste of a symposium – these one day conferences will bring together local physicians, members & their caregivers and loved ones.